Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Operating Officer and Chief Legal Officer
-
Stock Symbol
-
ANTX on Nasdaq
Joshua M. Eizen - trading volume in the past year for AN2 Therapeutics, Inc.
Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
175K |
$235K |
$1.34 |
Feb 26, 2025 |
Direct |
|
|
Stock Option (right to buy) |
117K |
|
|
Feb 26, 2025 |
Direct |
Common Stock |
|
Transactions reported by Joshua M. Eizen for AN2 Therapeutics, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.